Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amplia Therapeutics ( (AU:ATX) ) has issued an update.
Amplia Therapeutics Limited has announced the issuance of 1,000,000 fully paid ordinary shares, which will be quoted on the ASX under the code ATX. This move could potentially enhance the company’s capital structure, providing it with additional resources to further its research and development efforts in the biotechnology sector.
More about Amplia Therapeutics
Amplia Therapeutics Limited operates in the biotechnology industry, focusing on the development of therapeutic drugs. The company is primarily involved in creating treatments for diseases with significant unmet medical needs.
Average Trading Volume: 6,618,883
Technical Sentiment Signal: Buy
Current Market Cap: A$110.8M
For a thorough assessment of ATX stock, go to TipRanks’ Stock Analysis page.